Pediatric data add to Shire's ADHD package

Shire plc (LSE:SHP; NASDAQ:SHPG) said its SHP465 triple-bead mixed amphetamine salts (MAS) met the primary endpoint of improving ADHD symptoms in the Phase

Read the full 236 word article

User Sign In